TQC3721 suspension placebo for inhalation

DRUG2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease (COPD)

Phase 1

A Clinical Trial of TQC3721 Suspension for Inhalation

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chronic Obstructive Pulmonary Disease

Start: 2021-10-18End: 2022-12-31Target: 114Updated: 2021-10-25

Phase 2

A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

TerminatedNCT05292196

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chronic Obstructive Pulmonary Disease (COPD)

Start: 2022-05-20End: 2023-12-05Updated: 2025-04-20